SCHEMBL23985232

SCHEMBL23985232

CCNC(=O)c1cccc2cc[nH]c12

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 4/20 0.59
HDAC2 Q92769 3/20 0.59
HDAC3 O15379 3/20 0.59
HDAC4 P56524 2/20 0.59
HDAC7 Q8WUI4 2/20 0.59
HDAC10 Q969S8 2/20 0.59
HDAC11 Q96DB2 2/20 0.59
HDAC8 Q9BY41 2/20 0.59
HDAC6 Q9UBN7 2/20 0.59
HDAC9 Q9UKV0 2/20 0.59
HDAC5 Q9UQL6 2/20 0.59
KEAP1 Q14145 1/20 0.58
PDPK1 O15530 1/20 0.57
GRM5 P41594 1/20 0.53
MAPT P10636 4/20 0.52
KMT2A Q03164 3/20 0.52
KDM4E B2RXH2 2/20 0.52
RAB9A P51151 2/20 0.49
NPSR1 Q6W5P4 1/20 0.49
MEN1 O00255 2/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10244809 0.85 HDAC1 (0.67) HDAC1HDAC2HDAC3HDAC4HDAC7
SCHEMBL4723200 0.84 HDAC1 (0.55) HDAC1HDAC2HDAC3HDAC4HDAC7
SCHEMBL8294961 0.82 HDAC1 (0.57) HDAC1HDAC2HDAC3HDAC4HDAC7
SCHEMBL6219389 0.82 KEAP1 (0.64) HDAC1HDAC2HDAC3HDAC4HDAC7
SCHEMBL9973783 0.82 PDPK1 (0.67) HDAC1HDAC2HDAC3HDAC4HDAC7
SCHEMBL4719776 0.82 PDPK1 (0.62) HDAC1HDAC2HDAC3HDAC4HDAC7
SCHEMBL8291239 0.81 HDAC1 (0.59) HDAC1HDAC2HDAC3HDAC4HDAC7
SCHEMBL18067784 0.80 KEAP1 (0.54) HDAC1HDAC2HDAC3HDAC4HDAC7
SCHEMBL18067778 0.80 KEAP1 (0.54) HDAC1HDAC2HDAC3HDAC4HDAC7
SCHEMBL18067790 0.80 KEAP1 (0.54) HDAC1HDAC2HDAC3HDAC4HDAC7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021222556-A1 PI3K-α INHIBITORS AND METHODS OF USE THEREOF RELAY THERAPEUTICS, INC. (US) 2021-11-04 WO disclosed